APA (7th ed.) Citation

Penny, H. L., Hainline, K., Theoharis, N., Wu, B., Brandl, C., Webhofer, C., . . . Mytych, D. T. (2023). Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy. Frontiers in immunology, 14, . https://doi.org/10.3389/fimmu.2023.1261070

Chicago Style (17th ed.) Citation

Penny, Hweixian Leong, et al. "Characterization and Root Cause Analysis of Immunogenicity to Pasotuxizumab (AMG 212), a Prostate-specific Membrane Antigen-targeting Bispecific T-cell Engager Therapy." Frontiers in Immunology 14 (2023). https://doi.org/10.3389/fimmu.2023.1261070.

MLA (9th ed.) Citation

Penny, Hweixian Leong, et al. "Characterization and Root Cause Analysis of Immunogenicity to Pasotuxizumab (AMG 212), a Prostate-specific Membrane Antigen-targeting Bispecific T-cell Engager Therapy." Frontiers in Immunology, vol. 14, 2023, https://doi.org/10.3389/fimmu.2023.1261070.